Evidence map›Paper›PMID 32393788›Full record

ArticleNature communications2020

Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers.

Maira Di Tano, Franca Raucci, Claudio Vernieri, Irene Caffa, Roberta Buono, Maura Fanti, Sebastian Brandhorst, Giuseppe Curigliano, Alessio Nencioni, Filippo de Braud and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05763992 (Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting), which is not on this map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05763992 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial

TypeinterventionalSponsorFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRan2023 to 2026Enrolled145ConditionsBreast Cancer, Triple Negative Breast Cancer, Dietary Exposure, FastingArmsControl diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Iranian journal of basic medical sciences · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. [The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Maira Di TanoUniversity of Milan. Department of Oncology and Hemato-Oncology, Milan, Italy.ORCID http://orcid.org/0000-0003-1849-9404
Franca RaucciIFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
Claudio VernieriIFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
Irene CaffaDepartment of Internal Medicine, University of Genoa, Genoa, Italy.
Roberta BuonoLongevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-0033-5375
Maura FantiLongevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Sebastian BrandhorstLongevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Giuseppe CuriglianoUniversity of Milan. Department of Oncology and Hemato-Oncology, Milan, Italy.ORCID http://orcid.org/0000-0003-1781-2518
Alessio NencioniDepartment of Internal Medicine, University of Genoa, Genoa, Italy.ORCID http://orcid.org/0000-0001-5068-8884
Filippo de BraudUniversity of Milan. Department of Oncology and Hemato-Oncology, Milan, Italy.
Valter D LongoIFOM, FIRC Institute of Molecular Oncology, Milan, Italy. valter.longo@ifom.eu.ORCID http://orcid.org/0000-0002-0946-7534
University of Southern California · USUniversity of Milan · ITIFOM · ITOspedale Policlinico San Martino · IT

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
The Role of the Glucose-regulated Protein GRP78/BiP in Stress Resistance and AginP01AG034906 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LONGO, VALTER D. · 2011 to 2016
$9.3M
Role of Longevity Regulatory Pathways in Age-dependent Macro-molecular Damage inR01AG020642 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LONGO, VALTER D. · 2003 to 2017
$4.8M
NCATS NIH HHS UL1 TR001855NIA NIH HHS P01 AG034906NIA NIH HHS R01 AG020642
6 · The paper itself

Abstract

Fasting-mimicking diets delay tumor progression and sensitize a wide range of tumors to chemotherapy, but their therapeutic potential in combination with non-cytotoxic compounds is poorly understood. Here we show that vitamin C anticancer activity is limited by the up-regulation of the stress-inducible protein heme-oxygenase-1. The fasting-mimicking diet selectivity reverses vitamin C-induced up-regulation of heme-oxygenase-1 and ferritin in KRAS-mutant cancer cells, consequently increasing reactive iron, oxygen species, and cell death; an effect further potentiated by chemotherapy. In support of a potential role of ferritin in colorectal cancer progression, an analysis of The Cancer Genome Atlas Database indicates that KRAS mutated colorectal cancer patients with low intratumor ferritin mRNA levels display longer 3- and 5-year overall survival. Collectively, our data indicate that the combination of a fasting-mimicking diet and vitamin C represents a promising low toxicity intervention to be tested in randomized clinical trials against colorectal cancer and possibly other KRAS mutated tumors.

Indexed as

DietAnimalsAscorbic AcidCell DeathCell Line, TumorCell SurvivalDisease ProgressionFastingHeme Oxygenase-1HumansIronMice, Inbred BALB CMutationOxaliplatinPhosphorylationProto-Oncogene Proteins p21(ras)Ascorbic AcidHeme Oxygenase-1IronKRAS protein, humanOxaliplatinProto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesTransferrin

Identifiers

PMID32393788
PMCPMC7214421
OpenAlexW3021756656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.